Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300583 stock hub

SHE/300583 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300583is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300583

In the news

Latest news · SHE/300583

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/En/a

P25 23.5P50 41.3P75 83.2

ROE-10.2

P25 -0.9P50 4.1P75 8.8

ROIC-7.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300583 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

CNY

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	959
Employees Change	-241%
Employees Change Percent	-20.08
Enterprise value	CNY 3.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100002F36
Last refreshed	2026-05-10
Market cap	CNY 3B
Price	CNY 15.57
Price currency	CNY
Rev Per Employee	995,574.16x
Sector	Healthcare
Sic	2833
Symbol	she/300583
Website	https://www.sitobiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.85%
EV Earnings	-20.43x
EV/FCF	53.11x
EV/Sales	3.7x
FCF yield	2.25%
P/B ratio	1.64x
P/S ratio	3.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-17.83%
EBITDA Margin	-0.05%
FCF margin	6.96%
Gross margin	0.01%
Gross Profit	CNY 109,762
Gross Profit Growth	-99.95%
Gross Profit Growth3 Y	-92.61%
Gross Profit Growth5 Y	-75.27%
Net Income	CNY -172.7M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-20.81%
Profit Margin	-18.09%
Profit Per Employee	CNY -180,096
ROA	-3.57
Roa5y	0.1
ROCE	-9.04
ROE	-10.19
Roe5y	-1.74
ROIC	-7.4
Roic5y	-0.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.47%
Cagr3y	1.43%
Cagr5y	4.19%
Div CAGR3	28.71%
Div CAGR5	16.35%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	-26.81%
FCF Growth Q	-99.74%
FCF Growth3 Y	-25.55%
FCF Growth5 Y	-0.48%
OCF Growth	-31.18%
OCF Growth Q	20.82%
OCF Growth3 Y	-37.1%
OCF Growth5 Y	-14.97%
Revenue Growth	-14.88x
Revenue Growth Q	59.58x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-8.68x
Revenue Growth5 Y	1.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.32
Assets	CNY 2.9B
Cash	CNY 228.4M
Current Assets	CNY 1.3B
Current Liabilities	CNY 984.8M
Debt	CNY 722M
Debt EBITDA	CNY 173
Debt Equity	CNY 0.4
Debt FCF	CNY 10.87
Equity	CNY 1.8B
Interest Coverage	-8.12
Liabilities	CNY 1.1B
Long Term Assets	CNY 1.6B
Long Term Liabilities	CNY 80.1M
Net Cash	CNY -493.6M
Net Cash By Market Cap	CNY -16.71
Net Debt Equity	CNY 0.27
Net Debt FCF	CNY 7.43
Tangible Book Value	CNY 1.6B
Tangible Book Value Per Share	CNY 8.34
WACC	4.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.21
Inventory Turnover	1.61
Net Working Capital	CNY 639.9M
Quick ratio	0.69
Working Capital	CNY 207.1M
Working Capital Turnover	CNY 3.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.92%
Dividend Growth	-95.56%
Dividend Growth Years	0%
Dividend per share	CNY 0.01
Dividend Years	4
Dividend Yield	0.06%
Ex Div Date	2025-09-24
Last Dividend	CNY 0.01
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.46%
200-day SMA	15.38
3Y total return	4.36%
50-day SMA	14.4
50-day SMA vs 200-day SMA	50under200
5Y total return	22.77%
All Time High	58.39
All Time High Change	-73.34%
All Time High Date	2017-01-13
All Time Low	10.66
All Time Low Change	46.06%
All Time Low Date	2024-07-25
ATR	0.48
Beta	0.19
Beta1y	0.36
Beta2y	0.37
Ch YTD	13.73
High	15.68
High52	20.76
High52 Date	2025-05-09
High52ch	-26.03%
Low	15.16
Low52	12.82
Low52 Date	2026-03-23
Low52ch	21.45%
Ma50ch	8.1%
Price vs 200-day SMA	1.27%
RSI	67.22
RSI Monthly	47.28
RSI Weekly	54.44
Sharpe ratio	-0.82x
Sortino ratio	-0.94
Total Return	-11.85%
Tr YTD	13.73
Tr1m	8.13%
Tr1w	2.43%
Tr3m	5.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY -170.2M
Operating margin	-17.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	88,365,974%
Net Borrowing	-63,335,661
Shares Insiders	24.63%
Shares Institutions	1.78%
Shares Out	189,702,126
Shares Qo Q	-9.85%
Shares Yo Y	11.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 66.4M
Average Volume	3,286,438.7x
Bv Per Share	9.31
CAPEX	CNY -36.8M
Ch1m	8.13
Ch1w	2.43
Ch1y	-20.56
Ch3m	5.13
Ch3y	0.61
Ch5y	18.29
Ch6m	2.23
Change	1.76%
Change From Open	1.76
Close	15.3
Days Gap	0
Depreciation Amortization	169,801,496
Dollar Volume	71,180,839.6
Earnings Date	2026-04-28
EBIT	CNY -170.2M
EBITDA	CNY -446,474
EPS	CNY -0.89
F Score	2
FCF	CNY 66.4M
FCF EV Yield	1.88x
FCF Per Share	CNY 0.35
Financing CF	7,387,728
Fiscal Year End	December
Founded	2,002
Income Tax	CNY -5M
Investing CF	-23,444,105
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2023-08-25
Last Split Type	Forward
Ma150	14.65
Ma150ch	6.26%
Ma20	14.38
Ma20ch	8.28%
Net CF	88,397,741
Next Earnings Date	2026-08-26
Open	15.3
P FCF Ratio	44.46
P OCF Ratio	28.6
Payment Date	2025-09-24
Position In Range	78.85
Ppne	1,399,261,438
Price Date	2026-05-08
Ptbv Ratio	1.87
Relative Volume	1.39x
Revenue	954,755,619x
Tax By Revenue	-0.53x
Tr6m	2.23%
Volume	4,571,666

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300583 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.01 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+16.3%

0 consecutive years of growth

Total shareholder yield

-11.9%

Next ex-dividend date: 2025-09-24

Performance

SHE/300583 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300583?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.8%

Share of float held by funds and institutions

Insider ownership

+24.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+11.9%

Negative means the company is buying back shares.

Technical

SHE/300583 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.2

Neutral momentum band

Price vs 200-day MA

+1.3%

50/200-day relationship not available

Beta (5Y)

0.19

Less volatile than the market

Sharpe ratio

-0.82

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300583

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300583 stock rating?

she/300583 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300583 analysis?

The full report lives at /stocks/she/300583/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300583?

The latest report frames she/300583 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300583 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.